ALEJANDRO ARROLIGA to Antihypertensive Agents
This is a "connection" page, showing publications ALEJANDRO ARROLIGA has written about Antihypertensive Agents.
Connection Strength
0.512
-
Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan. South Med J. 2006 Aug; 99(8):880-3.
Score: 0.220
-
Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension. Drugs Today (Barc). 2004 Mar; 40(3):225-34.
Score: 0.186
-
Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension. Cleve Clin J Med. 2003 Apr; 70 Suppl 1:S18-27.
Score: 0.044
-
High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung. 2001; 179(4):233-43.
Score: 0.037
-
Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. Chest. 2007 Apr; 131(4):984-7.
Score: 0.014
-
The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages. J Biol Chem. 2002 Sep 06; 277(36):33344-8.
Score: 0.010